Glucose Biosensors: An Overview of Use in Clinical Practice

被引:684
作者
Yoo, Eun-Hyung [2 ]
Lee, Soo-Youn [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea
[2] Konyang Univ, Coll Med Sci, Konyang Univ Hosp, Dept Lab Med, Taejon, South Korea
关键词
diabetes mellitus; glucose biosensor; point-of-care testing; performance; self-monitoring of blood glucose; TYPE-2 DIABETES PATIENTS; BLOOD-GLUCOSE; NEEDLE-TYPE; ENZYME-ELECTRODE; AMPEROMETRIC DETERMINATION; POSITIVE INTERFERENCE; GLYCEMIC CONTROL; DEHYDROGENASE; DESIGN; CARE;
D O I
10.3390/s100504558
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Blood glucose monitoring has been established as a valuable tool in the management of diabetes. Since maintaining normal blood glucose levels is recommended, a series of suitable glucose biosensors have been developed. During the last 50 years, glucose biosensor technology including point-of-care devices, continuous glucose monitoring systems and noninvasive glucose monitoring systems has been significantly improved. However, there continues to be several challenges related to the achievement of accurate and reliable glucose monitoring. Further technical improvements in glucose biosensors, standardization of the analytical goals for their performance, and continuously assessing and training lay users are required. This article reviews the brief history, basic principles, analytical performance, and the present status of glucose biosensors in the clinical practice.
引用
收藏
页码:4558 / 4576
页数:19
相关论文
共 115 条
  • [1] CLINICAL CONTROL OF DIABETES BY ARTIFICIAL PANCREAS
    ALBISSER, AM
    LEIBEL, BS
    EWART, TG
    DAVIDOVAC, Z
    BOTZ, CK
    ZINGG, W
    SCHIPPER, H
    GANDER, R
    [J]. DIABETES, 1974, 23 (05) : 397 - 404
  • [2] Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc12-s011, 10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc13-S011, 10.2337/dc11-S062, 10.2337/dc12-s064, 10.2337/dc10-S011]
  • [3] Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc10-s062]
  • [4] Amercian diabetes associations, 1996, DIABETES CARE, V19, pS1
  • [5] [Anonymous], 2003, IN VITR DIAGN TEST S
  • [6] Azevedo AM, 2003, BIOTECHNOL ANN REV, V9, P199, DOI 10.1016/S1387-2656(03)09003-3
  • [7] Enzyme electrodes based on sono-gel containing ferrocenyl compounds
    Ballarin, Barbara
    Cassani, Maria Cristina
    Mazzoni, Rita
    Scavetta, Erika
    Tonelli, Domenica
    [J]. BIOSENSORS & BIOELECTRONICS, 2007, 22 (07) : 1317 - 1322
  • [8] Glucose oxidase - An overview
    Bankar, Sandip B.
    Bule, Mahesh V.
    Singhal, Rekha S.
    Ananthanarayan, Laxmi
    [J]. BIOTECHNOLOGY ADVANCES, 2009, 27 (04) : 489 - 501
  • [9] EFFECT OF HEMATOCRIT CONCENTRATION ON BLOOD-GLUCOSE VALUE DETERMINED ON GLUCOMETER-II
    BARREAU, PB
    BUTTERY, JE
    [J]. DIABETES CARE, 1988, 11 (02) : 116 - 118
  • [10] STRATEGIES FOR THE DEVELOPMENT OF AMPEROMETRIC ENZYME ELECTRODES
    BARTLETT, PN
    WHITAKER, RG
    [J]. BIOSENSORS, 1988, 3 (06) : 359 - 379